Literature DB >> 1723599

Conformational changes of recombinant human granulocyte-colony stimulating factor induced by pH and guanidine hydrochloride.

L O Narhi1, W C Kenney, T Arakawa.   

Abstract

Fluorescence and circular dichroism were used to follow the pH-dependent conformational changes of granulocyte colony stimulating factor (G-CSF). Tryptophan fluorescence of the spectra monitored at 344 nm, or after deconvolution of the emission spectra, at 345 nm, showed a decrease in intensity on going from pH 7 to 4, with a midtransition pH of 5.8. On the other hand, tyrosine fluorescence measured either by the ratio of intensity at 308 nm to that at 344 nm, or by the fluorescence intensity at 303 nm after deconvolution of the spectra, increased in intensity as the pH was changed from 6 to 2.5, with a midtransition pH of 4.5. Near UV circular dichroic spectra also showed changes between pH 7.5 and 4.5, which correlated with the transition monitored by the tryptophan fluorescence. The guanidine hydrochloride-induced conformational changes of G-CSF at five pH values from 2.5 to 7.5 were also studied. Circular dichroic and fluorescence spectra revealed minor conformational changes by the addition of 1 or 2 M guanidine HCl at all pH values examined, while the major conformational transition occurred between 2 and 4 M guanidine hydrochloride. The secondary structure of the protein was most stable between pH 3.3 and 4.5. The guanidine HCl-induced denaturation of G-CSF involved more than a two-state transition, with detectable intermediate(s) present, and the structure of the intermediate(s) appeared to depend on the pH used. These results are consistent with the pH dependence of the structure described above, and demonstrate the complex conformational properties of G-CSF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1723599     DOI: 10.1007/bf01025250

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  7 in total

Review 1.  The granulocyte-macrophage colony-stimulating factors.

Authors:  D Metcalf
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

2.  Cloning of granulocyte colony-stimulating factor cDNA from human macrophages and its expression in Escherichia coli.

Authors:  Y Komatsu; T Matsumoto; T Kuga; T Nishi; S Sekine; A Saito; M Okabe; M Morimoto; S Itoh; T Okabe
Journal:  Jpn J Cancer Res       Date:  1987-11

3.  Mutagenesis of human granulocyte colony stimulating factor.

Authors:  T Kuga; Y Komatsu; M Yamasaki; S Sekine; H Miyaji; T Nishi; M Sato; Y Yokoo; M Asano; M Okabe
Journal:  Biochem Biophys Res Commun       Date:  1989-02-28       Impact factor: 3.575

4.  Characterization of recombinant-derived granulocyte-colony stimulating factor (G-CSF).

Authors:  P Wingfield; R Benedict; G Turcatti; B Allet; J J Mermod; J DeLamarter; M G Simona; K Rose
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

5.  Disulfide and secondary structures of recombinant human granulocyte colony stimulating factor.

Authors:  H S Lu; T C Boone; L M Souza; P H Lai
Journal:  Arch Biochem Biophys       Date:  1989-01       Impact factor: 4.013

6.  In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor.

Authors:  A M Cohen; K M Zsebo; H Inoue; D Hines; T C Boone; V R Chazin; L Tsai; T Ritch; L M Souza
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

7.  Recombinant human granulocyte colony stimulating factor: molecular and biological characterization.

Authors:  K M Zsebo; A M Cohen; D C Murdock; T C Boone; H Inoue; V R Chazin; D Hines; L M Souza
Journal:  Immunobiology       Date:  1986-09       Impact factor: 3.144

  7 in total
  12 in total

1.  Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor.

Authors:  Eva Y Chi; Sampathkumar Krishnan; Brent S Kendrick; Byeong S Chang; John F Carpenter; Theodore W Randolph
Journal:  Protein Sci       Date:  2003-05       Impact factor: 6.725

2.  Monitoring Effects of Excipients, Formulation Parameters and Mutations on the High Order Structure of Filgrastim by NMR.

Authors:  Yves Aubin; Derek J Hodgson; William B Thach; Geneviève Gingras; Simon Sauvé
Journal:  Pharm Res       Date:  2015-06-05       Impact factor: 4.200

3.  Aggregation of granulocyte-colony stimulating factor in vitro involves a conformationally altered monomeric state.

Authors:  Stephen W Raso; Jeff Abel; Jesse M Barnes; Kevin M Maloney; Gary Pipes; Michael J Treuheit; Jonathan King; David N Brems
Journal:  Protein Sci       Date:  2005-09       Impact factor: 6.725

4.  Optimization and applications of CDAP labeling for the assignment of cysteines.

Authors:  Gary D Pipes; Andrew A Kosky; Jeffrey Abel; Yu Zhang; Michael J Treuheit; Gerd R Kleemann
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

5.  pH Dependence of structural stability of interleukin-2 and granulocyte colony-stimulating factor.

Authors:  Margaret Speed Ricci; Casim A Sarkar; Eric M Fallon; Douglas A Lauffenburger; David N Brems
Journal:  Protein Sci       Date:  2003-05       Impact factor: 6.725

6.  The kinetics of G-CSF folding.

Authors:  David N Brems
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

Review 7.  Effects of glycosylation on the stability of protein pharmaceuticals.

Authors:  Ricardo J Solá; Kai Griebenow
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

8.  Characterization of two fluorescent tryptophans in recombinant human granulocyte-colony stimulating factor: comparison of native sequence protein and tryptophan-deficient mutants.

Authors:  C G Kolvenbach; S Elliott; R Sachdev; T Arakawa; L O Narhi
Journal:  J Protein Chem       Date:  1993-04

9.  Induced resistance of trypsin to sodium dodecylsulfate upon complex formation with trypsin inhibitor.

Authors:  T Arakawa; L Hung; M G McGinley; M F Rohde; L O Narhi
Journal:  J Protein Chem       Date:  1992-04

10.  Cysteine 17 of recombinant human granulocyte-colony stimulating factor is partially solvent-exposed.

Authors:  T Arakawa; S J Prestrelski; L O Narhi; T C Boone; W C Kenney
Journal:  J Protein Chem       Date:  1993-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.